Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study

被引:0
|
作者
Georges Bucyibaruta
Marta Blangiardo
Garyfallos Konstantinoudis
机构
[1] Imperial College London,Department of Epidemiology and Biostatistics, MRC Centre for Environment and Health, School of Public Health
来源
关键词
COVID-19; Spatial modelling; Vaccine inequalities; Community-level characteristics;
D O I
暂无
中图分类号
学科分类号
摘要
One year after the start of the COVID-19 vaccination programme in England, more than 43 million people older than 12 years old had received at least a first dose. Nevertheless, geographical differences persist, and vaccine hesitancy is still a major public health concern; understanding its determinants is crucial to managing the COVID-19 pandemic and preparing for future ones. In this cross-sectional population-based study we used cumulative data on the first dose of vaccine received by 01-01-2022 at Middle Super Output Area level in England. We used Bayesian hierarchical spatial models and investigated if the geographical differences in vaccination uptake can be explained by a range of community-level characteristics covering socio-demographics, political view, COVID-19 health risk awareness and targeting of high risk groups and accessibility. Deprivation is the covariate most strongly associated with vaccine uptake (Odds Ratio 0.55, 95%CI 0.54-0.57; most versus least deprived areas). The most ethnically diverse areas have a 38% (95%CI 36-40%) lower odds of vaccine uptake compared with those least diverse. Areas with the highest proportion of population between 12 and 24 years old had lower odds of vaccination (0.87, 95%CI 0.85-0.89). Finally increase in vaccine accessibility is associated with COVID-19 vaccine coverage (OR 1.07, 95%CI 1.03-1.12). Our results suggest that one year after the start of the vaccination programme, there is still evidence of inequalities in uptake, affecting particularly minorities and marginalised groups. Strategies including prioritising active outreach across communities and removing practical barriers and factors that make vaccines less accessible are needed to level up the differences.
引用
收藏
页码:1071 / 1081
页数:10
相关论文
共 50 条
  • [11] COVID-19 vaccine hesitancy in the UK: a longitudinal household cross-sectional study
    Kausik Chaudhuri
    Anindita Chakrabarti
    Joht Singh Chandan
    Siddhartha Bandyopadhyay
    BMC Public Health, 22
  • [12] COVID-19 vaccine hesitancy in Ethiopia in 2021: a multicenter cross-sectional study
    Erega, Besfat Berihun
    Ferede, Wassie Yazie
    Sisay, Fillorenes Ayalew
    Tiruneh, Gebrehiwot Ayalew
    Ayalew, Abeba Belay
    Malka, Erean shigign
    Tassew, Habtamu Abie
    Alemu, Asrat
    IJID REGIONS, 2023, 6 : 120 - 124
  • [13] COVID-19 vaccine hesitancy in the UK: a longitudinal household cross-sectional study
    Chaudhuri, Kausik
    Chakrabarti, Anindita
    Chandan, Joht Singh
    Bandyopadhyay, Siddhartha
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [14] COVID-19 Knowledge, Attitudes, and Vaccine Hesitancy in Ethiopia: A Community-Based Cross-Sectional Study
    Muluneh, Muluken Dessalegn
    Negash, Kasahun
    Tsegaye, Sentayehu
    Abera, Yared
    Tadesse, Derbe
    Abebe, Sintayehu
    Vaughan, Cathy
    Stulz, Virginia
    VACCINES, 2023, 11 (04)
  • [15] Acceptance of COVID-19 Vaccine in Pakistan: A Nationwide Cross-Sectional Study
    Qamar, Mohammad Aadil
    Irfan, Omar
    Dhillon, Rubaid A.
    Bhatti, Areesh
    Sajid, Mir Ibrahim
    Awan, Safia
    Rizwan, Wajiha
    Zubairi, Ali Bin Sarwar
    Sarfraz, Zouina
    Khan, Javaid Ahmed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [16] Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
    Machida, Masaki
    Kikuchi, Hiroyuki
    Kojima, Takako
    Nakamura, Itaru
    Saito, Reiko
    Nakaya, Tomoki
    Hanibuchi, Tomoya
    Takamiya, Tomoko
    Odagiri, Yuko
    Fukushima, Noritoshi
    Amagasa, Shiho
    Watanabe, Hidehiro
    Inoue, Shigeru
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [17] Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy
    Bianco, Aida
    Della Polla, Giorgia
    Angelillo, Silvia
    Pelullo, Concetta P.
    Licata, Francesca
    Angelillo, Italo F.
    EXPERT REVIEW OF VACCINES, 2022, 21 (04) : 541 - 547
  • [18] COVID-19 vaccine hesitancy in multiple sclerosis: A cross-sectional survey
    Uhr, Lauren
    Mateen, Farrah J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1072 - 1080
  • [19] COVID-19 vaccine hesitancy in Chinese residents: A national cross-sectional survey in the community setting
    Zhao, Tianshuo
    Cai, Xianming
    Zhang, Sihui
    Wang, Mingting
    Chen, Linyi
    Li, Xikun
    Wang, Zhuangye
    Wang, Li
    Jiang, Wenguo
    Ha, Yu
    Li, Hui
    Liu, Yaqiong
    Lu, Qingbin
    Cui, Fuqiang
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [20] COVID-19 Vaccine Hesitancy: A Cross-Sectional Study of Visible Minority Canadian Communities
    Ochieng, Candy
    Petrucka, Pammla
    Mutwiri, George
    Szafron, Michael
    VACCINES, 2025, 13 (03)